CancerLinQ: origins, implementation, and future directions

SM Rubinstein, JL Warner - JCO clinical cancer informatics, 2018 - ascopubs.org
Rapid-learning health systems have been proposed as a potential solution to the problem of
quality in medicine, by leveraging data generated from electronic health systems in near …

Promoting scientist–advocate collaborations in cancer research: why and how

JM Salamone, W Lucas, SB Brundage, JN Holloway… - Cancer research, 2018 - AACR
Advocates bring unique and important viewpoints to the cancer research process, ensuring
that scientific and medical advances are patient-centered and relevant. In this article, we …

Comparing survival outcomes and costs associated with radical cystectomy and trimodal therapy for older adults with muscle-invasive bladder cancer

SB Williams, Y Shan, U Jazzar, HB Mehta… - JAMA …, 2018 - jamanetwork.com
Importance Radical cystectomy is the guidelines-recommended treatment of muscle-
invasive bladder cancer, but a resurgence of trimodal therapy has occurred. Limited …

[HTML][HTML] Palbociclib plus endocrine therapy in older women with HR+/HER2–advanced breast cancer: a pooled analysis of randomised PALOMA clinical studies

HS Rugo, NC Turner, RS Finn, AA Joy, S Verma… - European Journal of …, 2018 - Elsevier
Aim Because incidence of breast cancer and comorbidities increase with age, it is important
to determine treatment benefit in elderly patients. We evaluated outcomes with palbociclib …

Association of cardiovascular risk factors with cardiac events and survival outcomes among patients with breast cancer enrolled in SWOG clinical trials

DL Hershman, C Till, S Shen, JD Wright… - Journal of Clinical …, 2018 - ascopubs.org
Background Cardiovascular disease is the primary cause of death among patients with
breast cancer. However, the association of cardiovascular-disease risk factors (CVD-RFs) …

Expanding the evidence base in geriatric oncology: action items from an FDA-ASCO workshop

LA Levit, H Singh, HD Klepin… - JNCI: Journal of the …, 2018 - academic.oup.com
As part of the ongoing efforts to address the lack of clinical research on older adults with
cancer, the American Society of Clinical Oncology (ASCO) and the US Food and Drug …

[HTML][HTML] The addition of chemotherapy to radiation therapy improves survival in elderly patients with stage III non–small cell lung cancer

ED Miller, JL Fisher, KE Haglund, JC Grecula… - Journal of Thoracic …, 2018 - Elsevier
Introduction Elderly patients account for the majority of lung cancer diagnoses but are poorly
represented in clinical trials. We evaluated the overall survival (OS) of elderly patients with …

[HTML][HTML] Prevalence of multiple chronic conditions among older adults in Florida and the United States: comparative analysis of the OneFlorida data trust and national …

Z He, J Bian, HJ Carretta, J Lee, WR Hogan… - Journal of Medical …, 2018 - jmir.org
Background: Older patients with multiple chronic conditions are often faced with increased
health care needs and subsequent higher medical costs, posing significant financial burden …

[HTML][HTML] Cancer survivors not participating in observational patient-reported outcome studies have a lower survival compared to participants: the population-based …

BH de Rooij, NPM Ezendam, F Mols, PAJ Vissers… - Quality of Life …, 2018 - Springer
Abstract Purpose The 'Patient Reported Outcomes Following Initial treatment and Long-term
Evaluation of Survivorship'(PROFILES) registry collects patient-reported outcomes (PROs) …

Promoting accrual of older patients with cancer to clinical trials: an alliance for clinical trials in oncology member survey (A171602)

RA Freedman, TJ Dockter, JM Lafky, A Hurria… - The …, 2018 - academic.oup.com
Background There are multiple known individual‐and practice‐level barriers to enrollment of
older patients with cancer to clinical trials, but little is known about how the clinical research …